InsiderClue
Insiders · Profile

Nagendran Sukumar

President and Head of R&D at Taysha Gene Therapies. Filing since 2 Feb 2022. CIK 0001665124

Company
Date
Role
Action
Shares
Amount
Of holding
TSHA Taysha Gene Therapies, Inc.
10 Jul 2026
President and Head of R&D
Sold on a plan
200,000
$1.25M
17.6%
TSHA Taysha Gene Therapies, Inc.
10 Apr 2026
President and Head of R&D
Sold on a plan
200,000
$892.00K
15.0%
TSHA Taysha Gene Therapies, Inc.
26 Jan 2026
President and Head of R&D
Sold at will
26,918
$124.09K
2.0%
TSHA Taysha Gene Therapies, Inc.
23 Jan 2026
President and Head of R&D
Sold at will
89,132
$423.38K
6.2%
TSHA Taysha Gene Therapies, Inc.
12 Jan 2026
President and Head of R&D
Sold on a plan
200,000
$942.00K
16.6%
TSHA Taysha Gene Therapies, Inc.
1 Dec 2025
President and Head of R&D
Sold at will
260,047
$1.17M
20.5%
TSHA Taysha Gene Therapies, Inc.
28 Nov 2025
President and Head of R&D
Sold at will
110,125
$523.09K
9.9%
TSHA Taysha Gene Therapies, Inc.
10 Sep 2025
President and Head of R&D
Sold on a plan
200,000
$646.00K
16.6%
TSHA Taysha Gene Therapies, Inc.
21 Aug 2025
President and Head of R&D
Sold at will
57,054
$162.60K
4.7%
TSHA Taysha Gene Therapies, Inc.
16 May 2023
President and Head of R&D
Bought
5,000
$3.40K
17.1%
TSHA Taysha Gene Therapies, Inc.
2 Feb 2022
Director
Bought
10,000
$80.10K
52.0%
11 decisions on file.